Arcturus Therapeutics (ARCT) Gains 5.8% on Thermo Fisher Deal
Published on 7/2/2026
AI Summary
Summarized by AI from the source belowArcturus Therapeutics (ARCT) experienced a 5.8% increase following an agreement with Thermo Fisher. This deal signifies a strategic collaboration that could enhance Arcturus' operational capabilities and market positioning. The market reacted positively, indicating investor confidence in the partnership's potential benefits. Overall, this development may influence Arcturus' future stock performance as it leverages the resources provided through this collaboration.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
